Pneumocystis is a crucial opportunistic fungus that causes pneumonia in kids and immunocompromised people. Recent genomic knowledge present that divergence of main floor glycoproteins could confer speciation and host vary selectivity. On the opposite hand, immune clearance between mice and people is properly correlated. Thus, we hypothesized that humanize mice could present details about human immune responses concerned in controlling Pneumocystis an infection.
CD34-engrafted huNOG-EXL mice managed fungal burdens to a larger extent than nonengrafted mice. Moreover, engrafted mice generated fungal-specific IgM. Fungal management was related to a transcriptional signature that was enriched for genes related to nonopsonic recognition of trophs (CD209) and asci (CLEC7A). These similar genes had been downregulated in CD4-deficient mice in addition to twins with naked lymphocyte syndrome with Pneumocystis pneumonia.
Efficacy of Rezafungin in Prophylactic Mouse Models of Invasive Candidiasis, Aspergillosis, and Pneumocystis Pneumonia
Antifungal prophylaxis is advisable to stop invasive fungal illness attributable to Candida spp., Aspergillus spp., and Pneumocystis jirovecii in sufferers in danger for opportunistic infections, reminiscent of allogeneic blood or marrow transplant recipients, sufferers with hematological illness present process chemotherapy, or sufferers on immunosuppressive therapies.
Current approaches to antifungal prophylaxis require a number of brokers to cowl these key fungi. Rezafungin, a novel echinocandin designed for next-generation properties (e.g., larger stability and long-acting pharmacokinetics for once-weekly dosing), has demonstrated in vitro exercise towards Candida and Aspergillus spp. and efficacy towards Pneumocystis spp. biofilms.
Rezafungin was evaluated in in vivo research of prophylactic efficacy utilizing immunosuppressed mouse fashions of invasive candidiasis, aspergillosis, and Pneumocystis pneumonia. Rezafungin discount of Candida CFU burden was typically larger with growing drug concentrations (5, 10, or 20 mg/kg) and when rezafungin was administered nearer to the time of fungal problem (Days -1,-3, or-5).
Similarly, within the aspergillosis model, survival charges elevated with drug concentrations and when rezafungin was administered nearer to the time of fungal problem. Against P. murina, rezafungin considerably lowered trophic nuclei and asci counts in any respect doses examined.
Rezafungin prevented an infection on the 2 larger doses when put next with automobile and had comparable exercise to the lively management trimethoprim-sulfamethoxazole at human equal doses for prevention. These findings assist Phase Three growth of rezafungin and the potential for single-agent prophylaxis towards invasive fungal illness attributable to Candida spp., Aspergillus spp., and Pneumocystis jirovecii.
The Genus Acervus from Southwestern China and Northern Thailand
Acervus (Pyronemataceae, Pezizales) is a saprobic genus in Pezizomycetes, characterised by coloured apothecia, subcylindrical to cylindrical asci and guttulate ascospores. We collected 4 Acervus samples from China and Thailand. Descriptions and illustrations are launched for all recent samples. One new file of A. globulosus from Thailand, one new species, A. rufus, two recognized species, A. epispartius and A. stipitatus from China are reported.
Phylogenetic evaluation based mostly on 5 genes, the big subunit rRNA (LSU), the interpretation elongation factor-1 alpha (tef1-α), the second largest subunit of RNA polymerase II (rpb2), the biggest subunit of RNA polymerase II (rpb1), and the small subunit rRNA (SSU), revealed the distinct place of the brand new species. The new species is about aside by its crimson apothecia. A key to Acervus species can be given.
A Novel Encochleated Formulation Improves Atovaquone Activity in a Murine Model of Pneumocystis Pneumonia
Although atovaquone is efficient in treating and stopping Pneumocystis pneumonia (PCP), it is use is restricted by nonlinear absorption and hostile occasions. The present examine was undertaken to look at the exercise of encochleated atovaquone (eATQ), a novel lipid-crystal nanoparticle formulation, in a mouse model of PCP. eATQ 100 to 200 mg was superior to commercially accessible atovaquone at 14 days in lowering whole Pneumocystis nuclei and asci. eATQ plus anidulafungin lowered nuclei considerably higher than business atovaquone plus anidulafungin. eATQ is a novel formulation of atovaquone that warrants additional analysis for remedy and prevention of PCP.
Dynamic Sparse Subspace Clustering for Evolving High-Dimensional Data Streams
In an period of ubiquitous large-scale evolving knowledge streams, knowledge stream clustering (DSC) has obtained heaps of consideration as a result of the size of the info streams far exceeds the flexibility of knowledgeable human analysts. It has been noticed that high-dimensional knowledge are normally distributed in a union of low-dimensional subspaces. In this text, we suggest a novel sparse representation-based DSC algorithm, referred to as evolutionary dynamic sparse subspace clustering (EDSSC).
It can address the time-varying nature of subspaces underlying the evolving knowledge streams, reminiscent of subspace emergence, disappearance, and recurrence. The proposed EDSSC consists of two phases: 1) static studying and a couple of) on-line clustering.
During the primary part, a knowledge construction for storing the statistic abstract of knowledge streams, referred to as EDSSC abstract, is proposed which might higher deal with the dilemma between the 2 conflicting targets: 1) saving extra factors for accuracy of subspace clustering (SC) and a couple of) discarding extra factors for the effectivity of DSC.
By additional proposing an algorithm to estimate the subspace quantity, the proposed EDSSC doesn’t have to know the quantity of subspaces. In the second part, a extra appropriate index, referred to as the typical sparsity focus index (ASCI), is proposed, which dramatically promotes the clustering accuracy in comparison with the conventionally utilized SCI index.
 Anti-ATM antibody |
|
STJ97796 |
St John's Laboratory |
200 µl |
EUR 197 |
|
Description: Mouse monoclonal to ATM. |
Anti-ATM antibody |
|
STJ97797 |
St John's Laboratory |
200 µl |
EUR 197 |
|
Description: Mouse monoclonal to ATM. |
 Anti-Atm antibody |
|
STJ97855 |
St John's Laboratory |
100 µl |
EUR 234 |
|
Description: Mouse monoclonal to Atm. |
Anti-Atm antibody |
|
STJ91762 |
St John's Laboratory |
200 µl |
EUR 197 |
|
Description: Rabbit polyclonal to Atm. |
Anti-Atm antibody |
|
STJ91763 |
St John's Laboratory |
200 µl |
EUR 197 |
|
Description: Rabbit polyclonal to Atm. |
 Rabbit Polyclonal antibody Anti-CRBN |
|
Anti-CRBN |
ImmunoStep |
50 µg |
EUR 349 |
 anti-ATM |
|
YF-PA23267 |
Abfrontier |
50 ul |
EUR 334 |
|
Description: Mouse polyclonal to ATM |
 ELISA Kit) Human Ataxia Telangiectasia Mutated (ATM) ELISA Kit |
|
RD-ATM-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 500 |
Human Ataxia Telangiectasia Mutated (ATM) ELISA Kit |
|
RD-ATM-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 692 |
 ELISA Kit) Mouse Ataxia Telangiectasia Mutated (ATM) ELISA Kit |
|
RD-ATM-Mu-48Tests |
Reddot Biotech |
48 Tests |
EUR 511 |
Mouse Ataxia Telangiectasia Mutated (ATM) ELISA Kit |
|
RD-ATM-Mu-96Tests |
Reddot Biotech |
96 Tests |
EUR 709 |
Human Ataxia Telangiectasia Mutated (ATM) ELISA Kit |
|
DLR-ATM-Hu-48T |
DL Develop |
48T |
EUR 498 |
|
|
|
Description: A sandwich quantitative ELISA assay kit for detection of Human Ataxia Telangiectasia Mutated (ATM) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Human Ataxia Telangiectasia Mutated (ATM) ELISA Kit |
|
DLR-ATM-Hu-96T |
DL Develop |
96T |
EUR 647 |
|
|
|
Description: A sandwich quantitative ELISA assay kit for detection of Human Ataxia Telangiectasia Mutated (ATM) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Mouse Ataxia Telangiectasia Mutated (ATM) ELISA Kit |
|
DLR-ATM-Mu-48T |
DL Develop |
48T |
EUR 508 |
|
|
|
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Ataxia Telangiectasia Mutated (ATM) in samples from serum, plasma, tissue homogenates, cell lysates or other biological fluids. |
Mouse Ataxia Telangiectasia Mutated (ATM) ELISA Kit |
|
DLR-ATM-Mu-96T |
DL Develop |
96T |
EUR 661 |
|
|
|
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Ataxia Telangiectasia Mutated (ATM) in samples from serum, plasma, tissue homogenates, cell lysates or other biological fluids. |
Human Ataxia Telangiectasia Mutated (ATM) ELISA Kit |
|
RDR-ATM-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 522 |
Human Ataxia Telangiectasia Mutated (ATM) ELISA Kit |
|
RDR-ATM-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 724 |
Mouse Ataxia Telangiectasia Mutated (ATM) ELISA Kit |
|
RDR-ATM-Mu-48Tests |
Reddot Biotech |
48 Tests |
EUR 534 |
Mouse Ataxia Telangiectasia Mutated (ATM) ELISA Kit |
|
RDR-ATM-Mu-96Tests |
Reddot Biotech |
96 Tests |
EUR 742 |
 Anti-ATM Monoclonal Antibody |
|
M00014 |
BosterBio |
100ug |
EUR 397 |
|
Description: Rabbit Monoclonal ATM Antibody. Validated in Flow Cytometry, IF, IHC, ICC, WB and tested in Human. |
Anti-ATM Monoclonal Antibody |
|
M00014-1 |
BosterBio |
100ug |
EUR 397 |
|
Description: Rabbit Monoclonal ATM Antibody. Validated in IP, IF, WB and tested in Human, Mouse, Rat. |
) anti-ATM (1B10) |
|
LF-MA0246 |
Abfrontier |
100 ul |
EUR 334 |
|
Description: Mouse monoclonal to ATM |
) anti-ATM (9A2) |
|
LF-MA0254 |
Abfrontier |
100 ul |
EUR 334 |
|
Description: Mouse monoclonal to ATM |
) anti-ATM (5C5) |
|
LF-MA30535 |
Abfrontier |
100 ul |
EUR 527 |
|
Description: Mouse Monoclonal to ATM |
) Anti-ATM (2C10) |
|
YF-MA12031 |
Abfrontier |
100 ug |
EUR 363 |
|
Description: Mouse monoclonal to ATM |
 Anti-Phospho-ATM S1981 Antibody |
|
P00014 |
BosterBio |
100uL |
EUR 443 |
|
Description: Sheep Polyclonal Phospho-ATM S1981 Antibody. Validated in WB and tested in Human. |
 antibody) Anti-Phospho-ATM-(S1981) antibody |
|
STJ22028 |
St John's Laboratory |
100 µl |
EUR 393 |
|
Description: The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. |
 antibody) Anti-Phospho-Atm (S1981) antibody |
|
STJ97691 |
St John's Laboratory |
200 µl |
EUR 197 |
|
Description: Rabbit polyclonal to Phospho-Atm (S1981). |
 ATM Antibody |
|
1-CSB-PA243808 |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against ATM. Recognizes ATM from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC-p:1:100-200 |
ATM Antibody |
|
1-CSB-PA020042 |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against ATM. Recognizes ATM from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;IHC:1/100-1/300.ELISA:1/40000 |
ATM Antibody |
|
1-CSB-PA020043 |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against ATM. Recognizes ATM from Human. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/100-1/300.ELISA:1/10000 |
ATM Antibody |
|
1-CSB-PA612595 |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against ATM. Recognizes ATM from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC-p:1:100-200 |
ATM Antibody |
|
24457-100ul |
SAB |
100ul |
EUR 390 |
ATM Antibody |
|
48744-100ul |
SAB |
100ul |
EUR 333 |
ATM Antibody |
|
48744-50ul |
SAB |
50ul |
EUR 239 |
ATM Antibody |
|
BF0374 |
Affbiotech |
200ul |
EUR 376 |
|
Description: ATM antibody detects endogenous levels of total ATM. |
ATM Antibody |
|
AF4119 |
Affbiotech |
200ul |
EUR 376 |
|
Description: The antibody detects endogenous level of total ATM protein. |
 ATM antibody |
|
10-2477 |
Fitzgerald |
250 ug |
EUR 492 |
|
Description: Mouse monoclonal ATM antibody |
ATM antibody |
|
20R-1978 |
Fitzgerald |
50 ug |
EUR 281 |
|
Description: Rabbit polyclonal ATM antibody |
ATM antibody |
|
20R-2320 |
Fitzgerald |
50 ug |
EUR 281 |
|
Description: Rabbit polyclonal ATM antibody |
ATM antibody |
|
10R-8528 |
Fitzgerald |
100 ul |
EUR 393 |
|
Description: Mouse monoclonal ATM antibody |
ATM antibody |
|
10R-8536 |
Fitzgerald |
100 ul |
EUR 393 |
|
Description: Mouse monoclonal ATM antibody |
ATM antibody |
|
10R-11249 |
Fitzgerald |
100 ug |
EUR 349 |
|
Description: Mouse Monoclonal ATM antibody |
ATM antibody |
|
10R-1413 |
Fitzgerald |
100 ug |
EUR 512 |
|
Description: Mouse monoclonal ATM antibody |
ATM Antibody |
|
3945-002mg |
ProSci |
0.02 mg |
EUR 171.82 |
|
|
|
Description: ATM Antibody: DNA double strand breaks represent a major threat to an organism's genome. Eukaryotic cells have developed mechanisms that sense the presence this damage and initiate suitable responses that can include DNA repair, cell cycle delay, and programmed cell death. The ATM (mutated in Ataxia-Telangiectasia) protein kinase is activated following the formation of DNA double strand breaks, phosphorylating p53 and another kinase CHK2. This initiates a signaling cascade leading to the phosphorylation and inhibition of Cdc25, ultimately preventing cell cycle progression. In some cell types, such as the hemapoietic system, this leads to apoptosis instead of cell cycle arrest. Multiple isoforms of ATM are known to exist. |
ATM Antibody |
|
3945-01mg |
ProSci |
0.1 mg |
EUR 436.42 |
|
|
|
Description: ATM Antibody: DNA double strand breaks represent a major threat to an organism's genome. Eukaryotic cells have developed mechanisms that sense the presence this damage and initiate suitable responses that can include DNA repair, cell cycle delay, and programmed cell death. The ATM (mutated in Ataxia-Telangiectasia) protein kinase is activated following the formation of DNA double strand breaks, phosphorylating p53 and another kinase CHK2. This initiates a signaling cascade leading to the phosphorylation and inhibition of Cdc25, ultimately preventing cell cycle progression. In some cell types, such as the hemapoietic system, this leads to apoptosis instead of cell cycle arrest. Multiple isoforms of ATM are known to exist. |
ATM antibody |
|
70R-35069 |
Fitzgerald |
100 ug |
EUR 327 |
|
Description: Purified Rabbit polyclonal ATM antibody |
ATM antibody |
|
70R-12109 |
Fitzgerald |
100 ul |
EUR 447 |
|
Description: Rabbit polyclonal ATM antibody |
ATM antibody |
|
70R-14321 |
Fitzgerald |
100 ug |
EUR 322 |
|
Description: Affinity purified Rabbit polyclonal ATM antibody |
ATM antibody |
|
70R-51247 |
Fitzgerald |
100 ul |
EUR 287 |
|
Description: Purified Polyclonal ATM antibody |
ATM antibody |
|
70R-51248 |
Fitzgerald |
100 ul |
EUR 287 |
|
Description: Purified Polyclonal ATM antibody |
ATM antibody |
|
70R-51249 |
Fitzgerald |
100 ul |
EUR 244 |
|
Description: Purified Polyclonal ATM antibody |
ATM antibody |
|
70R-37584 |
Fitzgerald |
100 ug |
EUR 273 |
|
Description: Rabbit Polyclonal ATM antibody |
) anti-ATM (Phospho-Ser1981) |
|
LF-PA20039 |
Abfrontier |
100 ul |
EUR 354 |
|
Description: Rabbit polyclonal to ATM (Phospho-Ser1981) |
) anti-ATM (Ab-1981) |
|
LF-PA20659 |
Abfrontier |
100 ul |
EUR 334 |
|
Description: Rabbit polyclonal to ATM |
 Antibody) Serine-Protein Kinase ATM (ATM) Antibody |
|
20-abx125295 |
Abbexa |
-
EUR 495.00
-
EUR 704.00
-
EUR 356.00
|
|
|
|
Serine-Protein Kinase ATM (ATM) Antibody |
|
20-abx322869 |
Abbexa |
|
|
|
|
Serine-Protein Kinase ATM (ATM) Antibody |
|
20-abx004526 |
Abbexa |
-
EUR 411.00
-
EUR 592.00
-
EUR 182.00
-
EUR 314.00
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
|
Serine-Protein Kinase ATM (ATM) Antibody |
|
abx011708-100ul |
Abbexa |
100 ul |
EUR 411 |
|
|
 Antibody) Serine-protein kinase ATM (ATM) Antibody |
|
20-abx159339 |
Abbexa |
|
|
|
|
Serine-protein kinase ATM (ATM) Antibody |
|
20-abx159340 |
Abbexa |
|
|
|
|
Serine-protein kinase ATM (ATM) Antibody |
|
20-abx159341 |
Abbexa |
|
|
|
|
Serine-Protein Kinase ATM (ATM) Antibody |
|
20-abx326843 |
Abbexa |
|
|
|
|
Serine-Protein Kinase ATM (ATM) Antibody |
|
20-abx326844 |
Abbexa |
|
|
|
|
Serine-Protein Kinase ATM (ATM) Antibody |
|
20-abx325261 |
Abbexa |
|
|
|
|
 Atm Polyclonal Antibody |
|
ES6348-100ul |
ELK Biotech |
100ul |
EUR 279 |
|
Description: A Rabbit Polyclonal antibody against Atm from Human/Mouse. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
Atm Polyclonal Antibody |
|
ES6348-50ul |
ELK Biotech |
50ul |
EUR 207 |
|
Description: A Rabbit Polyclonal antibody against Atm from Human/Mouse. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
Atm Polyclonal Antibody |
|
ES6349-100ul |
ELK Biotech |
100ul |
EUR 279 |
|
Description: A Rabbit Polyclonal antibody against Atm from Human. This antibody is tested and validated for IHC, WB, ELISA |
Atm Polyclonal Antibody |
|
ES6349-50ul |
ELK Biotech |
50ul |
EUR 207 |
|
Description: A Rabbit Polyclonal antibody against Atm from Human. This antibody is tested and validated for IHC, WB, ELISA |
 ATM Polyclonal Antibody |
|
EA323-100ul |
ELK Biotech |
100ul |
EUR 279 |
|
Description: A Rabbit Polyclonal antibody against ATM from Human/ Rat/ Mouse. This antibody is tested and validated for IHC |
ATM Polyclonal Antibody |
|
EA323-50ul |
ELK Biotech |
50ul |
EUR 207 |
|
Description: A Rabbit Polyclonal antibody against ATM from Human/ Rat/ Mouse. This antibody is tested and validated for IHC |
 Polyclonal ATM Antibody |
|
APR00204G |
Leading Biology |
0.1ml |
EUR 484 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human ATM . This antibody is tested and proven to work in the following applications: |
Polyclonal ATM Antibody |
|
APR06420G |
Leading Biology |
0.1 mg |
EUR 659 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human ATM . This antibody is tested and proven to work in the following applications: |
 Antibody) ATM (pS1981) Antibody |
|
20-abx119523 |
Abbexa |
-
EUR 314.00
-
EUR 98.00
-
EUR 398.00
-
EUR 495.00
|
- 100 ug
- 10 ug
- 200 ug
- 300 µg
|
|
|
ATM (pS1981) Antibody |
|
20-abx121839 |
Abbexa |
-
EUR 314.00
-
EUR 467.00
-
EUR 203.00
|
|
|
|
Atm Polyclonal Antibody |
|
ABP55349-003ml |
Abbkine |
0.03ml |
EUR 158 |
|
|
|
Description: A polyclonal antibody for detection of Atm from Human, Mouse. This Atm antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Atm around the non-phosphorylation site of S1981 |
Atm Polyclonal Antibody |
|
ABP55349-01ml |
Abbkine |
0.1ml |
EUR 289 |
|
|
|
Description: A polyclonal antibody for detection of Atm from Human, Mouse. This Atm antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Atm around the non-phosphorylation site of S1981 |
Atm Polyclonal Antibody |
|
ABP55349-02ml |
Abbkine |
0.2ml |
EUR 414 |
|
|
|
Description: A polyclonal antibody for detection of Atm from Human, Mouse. This Atm antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Atm around the non-phosphorylation site of S1981 |
Atm Polyclonal Antibody |
|
ABP55350-003ml |
Abbkine |
0.03ml |
EUR 158 |
|
|
|
Description: A polyclonal antibody for detection of Atm from Human. This Atm antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Atm around the non-phosphorylation site of S1981 |
Atm Polyclonal Antibody |
|
ABP55350-01ml |
Abbkine |
0.1ml |
EUR 289 |
|
|
|
Description: A polyclonal antibody for detection of Atm from Human. This Atm antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Atm around the non-phosphorylation site of S1981 |
Atm Polyclonal Antibody |
|
ABP55350-02ml |
Abbkine |
0.2ml |
EUR 414 |
|
|
|
Description: A polyclonal antibody for detection of Atm from Human. This Atm antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Atm around the non-phosphorylation site of S1981 |
 Antibody) ATM (pS1987) Antibody |
|
abx148400-100ug |
Abbexa |
100 ug |
EUR 439 |
|
|
 Antibody) ATM (pS367) Antibody |
|
abx148401-100ug |
Abbexa |
100 ug |
EUR 439 |
|
|
 Antibody) ATM (pS183) Antibody |
|
abx148402-100ug |
Abbexa |
100 ug |
EUR 439 |
|
|
ATM (pS1981) Antibody |
|
abx148403-100ug |
Abbexa |
100 ug |
EUR 439 |
|
|
 Antibody) ATM (pS794) Antibody |
|
abx148404-100ug |
Abbexa |
100 ug |
EUR 439 |
|
|
ATM (pS1981) Antibody |
|
20-abx000098 |
Abbexa |
-
EUR 495.00
-
EUR 704.00
-
EUR 217.00
-
EUR 356.00
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
|
ATM (pS1981) Antibody |
|
20-abx000358 |
Abbexa |
-
EUR 495.00
-
EUR 704.00
-
EUR 356.00
|
|
|
|
ATM (pS1987) Antibody |
|
20-abx009872 |
Abbexa |
-
EUR 314.00
-
EUR 467.00
-
EUR 203.00
|
|
|
|
ATM (pS1981) Antibody |
|
20-abx009873 |
Abbexa |
-
EUR 314.00
-
EUR 467.00
-
EUR 203.00
|
|
|
|
In addition, the subspace evolution detection model based mostly on the Page-Hinkley take a look at is proposed the place the showing, disappearing, and recurring subspaces may be detected and tailored. Extinct experiments on real-world knowledge streams present that the EDSSC outperforms the state-of-the-art on-line SC approaches.
